Vilmos Fülöp
About
In The Last Decade
Vilmos Fülöp
45 papers receiving 675 citations
Peers
Comparison fields: 5 of 70
- Public Health, Environmental and Occupational Health 291
- Pediatrics, Perinatology and Child Health 238
- Organic Chemistry 141
- Obstetrics and Gynecology 133
- Immunology 128
Countries citing papers authored by Vilmos Fülöp
This map shows the geographic impact of Vilmos Fülöp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilmos Fülöp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilmos Fülöp more than expected).
Fields of papers citing papers by Vilmos Fülöp
This network shows the impact of papers produced by Vilmos Fülöp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilmos Fülöp. The network helps show where Vilmos Fülöp may publish in the future.
Co-authorship network of co-authors of Vilmos Fülöp
This figure shows the co-authorship network connecting the top 25 collaborators of Vilmos Fülöp. A scholar is included among the top collaborators of Vilmos Fülöp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilmos Fülöp. Vilmos Fülöp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | The Role of Surgery in the Management of Gestational Trophoblastic Neoplasia The Hungarian Experience. | 5 |
| 5 | Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta. | 17 |
| 6 | 28 | |
| 7 | 30 | |
| 8 | Immune cell profiling in intraplacental and postmolar choriocarcinomas. | 6 |
| 9 | 14 | |
| 10 | 22 | |
| 11 | 13 | |
| 12 | 9 | |
| 13 | 51 | |
| 14 | c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. | 65 |
| 15 | 19 | |
| 16 | 3 | |
| 17 | 10 | |
| 18 | 17 | |
| 19 | 6 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.